BROOKS LABORATORIES
Back to All Ratios
|
BROOKS LABORATORIES Last 5 Year EBIT Margin History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
EBIT Margin(%) | -57.27 | -22.81 | -7.63 |
What is the latest EBIT Margin ratio of BROOKS LABORATORIES ?
Year | EBIT Margin |
---|---|
Mar2023 | -57.27 |
Mar2022 | -22.81 |
Mar2021 | -7.63 |
How is EBIT Margin of BROOKS LABORATORIES Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2023 | -57.27 | Negative | |
Mar2022 | -22.81 | Negative | |
Mar2021 | -7.63 | - |
Other Financial Ratios of BROOKS LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of BROOKS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BROOKS LABORATORIES | ₹274.1 Cr | 4% | 10.1% | 71.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
BROOKS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BROOKS LABORATORIES | 4% |
10.1% |
71.6% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses